View of Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis

Return to Article Details Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis Download Download PDF

Cited by

	All	Since 2021
Citations	4983	4753
h-index	27	27
i10-index	114	114

0

2300

1150

575

1725

20152016201720182019202020212022202320242025202619 18 22 30 44 60 101 300 357 591 2230 1117